Moderate hyperosmolar hyponatremia caused by excessive off-label use of icodextrin during peritoneal dialysis
- PMID: 37082719
- PMCID: PMC10112000
- DOI: 10.5414/CNCS110854
Moderate hyperosmolar hyponatremia caused by excessive off-label use of icodextrin during peritoneal dialysis
Abstract
Icodextrin use during the long dwell of a peritoneal dialysis (PD) regimen is commonly used to increase ultrafiltration. Its use may cause a mild and clinically insignificant degree of hyponatremia. We describe a patient who was admitted twice to our medical center on an atypical continuous ambulatory peritoneal dialysis (CAPD) regimen utilizing solely icodextrin with 2 exchanges (12-hour dwells). On both admissions, he had hyperosmolar hyponatremia in the 120-mmol/L range with a large osmolal gap. After icodextrin was stopped and his PD prescription was switched to dextrose solutions, both hyponatremia corrected and the osmolal gap quickly disappeared. The accumulation of osmotically active solute in extracellular fluids results in efflux of water from the cellular compartment and produces both hyponatremia and hypertonicity [1]. This tonic effect occurs most frequently with hyperglycemia, but other substances can also cause this, including mannitol, sorbitol, glycine, and maltose [1, 2]. In this report, we present a patient with end-stage renal disease (ERSD) on an atypical off-label PD regimen utilizing solely icodextrin solutions who developed hyperosmolar hyponatremia in the 120-mmol/L range, with a large osmolal gap. This appeared to be due to absorbed metabolites of icodextrin, mainly maltose.
Keywords: hyponatremia; icodextrin; osmolal gap; peritoneal dialysis.
© Dustri-Verlag Dr. K. Feistle.
Conflict of interest statement
None of the authors involved writing this paper has any conflict of interest. Table 1.Serum chemistries, osmolalities, and osmolal gap during two admissions. TimeSodium (mmol/L)Glucose (mmol/L)Urea (mmol/L)Measured plasma OSm (mOsm/kg H2O)*Calculated plasma OSm (mOsm/kg H2O)**Osmolal gap (mosm/L)***First admission Day 11265.327.5284 Day 21264.823.93 Day 31314.823.2130729017 Day 9131524.6430629214Second admission Day 11225.329.28 Day 21224.631.4230527827 Day 31246.128.2130828226 Day 71285.124.28Icodextrin stopped 1.5%g dextrose solution Day 11304.321.782942859 Day 61345.218.932922920 Day 81355.318.93Throughout the first admission and the first week of second admission patient received solely icodextrin solutions at peritoneal dialysis. Then icodextrin solution was discontinued and replaced with 1.5% dextrose solutions. *The measured plasma osmolarity (pOsm) was performed utilizing the freezing point depression. **pOsm was calculated by the formula: pOsm = 2 (Na) + glucose (mmol/L) + urea (mmol/L). ***The osmolal gap was calculated as the difference of the osmolalities (measured pOsm – calculated pOsm). Figure 1Linear regression analysis of serum sodium and the plasma osmolal gap (osmolal gap = calculated – measured plasma osmolality). Table 2.Reported decrease in serum Na+ concentration with icodextrin use in peritoneal dialysis. AuthorYearDecrease in serum Na+ level (mEq/L)Dwell timeGradden et al. [5]2001Diabetics: 3.17; nondiabetics: 5.19Long single dwell time (unspecified)Gokal et al. [11]20023.68-hour overnight dwellPlum et al. [12]20023 – 7Mean long dwell time: 13.4 ± 1.2 hoursWolfson et al. [13]20022.8Long dwell (dwell time, 8 to 16 hours)Dimitriadis et al. [14]20143.5Not specifiedOlszowska et al. [10]20192.216-hour dwell
Figures
Similar articles
-
High Osmol Gap Hyponatremia Caused by Icodextrin: A Case Series Report.Am J Nephrol. 2024;55(2):202-205. doi: 10.1159/000533600. Epub 2023 Aug 14. Am J Nephrol. 2024. PMID: 37579741
-
Icodextrin Simplifies PD Therapy by Equalizing UF and Sodium Removal Among Patient Transport Types During Long Dwells: A Modeling Study.Perit Dial Int. 2016 Jan-Feb;36(1):79-84. doi: 10.3747/pdi.2013.00081. Epub 2014 Sep 2. Perit Dial Int. 2016. PMID: 25185017 Free PMC article.
-
Pharmacokinetics of icodextrin in peritoneal dialysis patients.Kidney Int Suppl. 2002 Oct;(81):S23-33. doi: 10.1046/j.1523-1755.62.s81.5.x. Kidney Int Suppl. 2002. PMID: 12230479
-
Icodextrin: a review of its use in peritoneal dialysis.Drugs. 2003;63(19):2079-105. doi: 10.2165/00003495-200363190-00011. Drugs. 2003. PMID: 12962523 Review.
-
Icodextrin provides long dwell peritoneal dialysis and maintenance of intraperitoneal volume.Artif Organs. 1998 Jan;22(1):8-12. doi: 10.1046/j.1525-1594.1998.06055.x. Artif Organs. 1998. PMID: 9456219 Review.
References
-
- Palevsky PM Rendulic D Diven WF Maltose-induced hyponatremia. Ann Intern Med. 1993; 118: 526–528. - PubMed
-
- Silver SA Harel Z Perl J Practical considerations when prescribing icodextrin: a narrative review. Am J Nephrol. 2014; 39: 515–527. - PubMed
-
- Uribarri J Prabhakar S Kahn T Hyponatremia in peritoneal dialysis patients. Clin Nephrol. 2004; 61: 54–58. - PubMed
-
- Gradden CW Ahmad R Bell GM Peritoneal dialysis: new developments and new problems. Diabet Med. 2001; 18: 360–363. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous